APA

Shepherd T. A., Edelstyn N. M. J., Longshaw L., Sim J., Watts K., Mayes A. R., Murray M. & Ellis S. J. (2018). Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment. : Pilot and feasibility studies.

Chicago

Shepherd Thomas A, Edelstyn Nicola M J, Longshaw Laura, Sim Julius, Watts Keira, Mayes Andrew R, Murray Michael and Ellis Simon J. 2018. Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment. : Pilot and feasibility studies.

Harvard

Shepherd T. A., Edelstyn N. M. J., Longshaw L., Sim J., Watts K., Mayes A. R., Murray M. and Ellis S. J. (2018). Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment. : Pilot and feasibility studies.

MLA

Shepherd Thomas A, Edelstyn Nicola M J, Longshaw Laura, Sim Julius, Watts Keira, Mayes Andrew R, Murray Michael and Ellis Simon J. Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment. : Pilot and feasibility studies. 2018.